These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10217310)

  • 21. The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat.
    Fredenburg AM; Sethi RK; Allen DD; Yokel RA
    Toxicology; 1996 Apr; 108(3):191-9. PubMed ID: 8658538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
    Kontoghiorghes GJ; Kolnagou A
    Lancet; 2003 Jan; 361(9352):184. PubMed ID: 12531621
    [No Abstract]   [Full Text] [Related]  

  • 23. Uptake, intracellular transport and release of 125I-poly(vinylpyrrolidone) and [14C]-sucrose-asialofetuin in rat liver parenchymal cells. Effects of ammonia on the intracellular transport.
    England IG; Naess L; Blomhoff R; Berg T
    Biochem Pharmacol; 1986 Jan; 35(2):201-8. PubMed ID: 2417605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.
    Kattamis A; Kassou C; Berdousi H; Ladis V; Papassotiriou I; Kattamis C
    Haematologica; 2003 Dec; 88(12):1423-5. PubMed ID: 14687998
    [No Abstract]   [Full Text] [Related]  

  • 25. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
    Chua AC; Ingram HA; Raymond KN; Baker E
    Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fate of homologous 125I-labelled immunoglobulin G within rat visceral yolk sacs incubated in vitro.
    Weisbecker U; Ibbotson GE; Livesey G; Williams KE
    Biochem J; 1983 Sep; 214(3):815-22. PubMed ID: 6626158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.
    Ma Y; de Groot H; Liu Z; Hider RC; Petrat F
    Biochem J; 2006 Apr; 395(1):49-55. PubMed ID: 16336208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of molecular size of 125I-labelled poly(vinylpyrrolidone) on its pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages.
    Duncan R; Pratten MK; Cable HC; Ringsdorf H; Lloyd JB
    Biochem J; 1981 Apr; 196(1):49-55. PubMed ID: 7306079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
    Florence A; Ward RJ; Peters TJ; Crichton RR
    Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes.
    Rice-Evans C; Baysal E; Singh S; Jones SA; Jones JG
    FEBS Lett; 1989 Oct; 256(1-2):17-20. PubMed ID: 2806543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPLC determination of 1,2-diethyl-3-hydroxypyridin-4-one (CP94), its iron complex [Fe(III) (CP94)3] and glucuronide conjugate [CP94-GLUC] in serum and urine of thalassaemic patients.
    Epemolu RO; Ackerman R; Porter JB; Hider RC; Damani LA; Singh S
    J Pharm Biomed Anal; 1994 Jul; 12(7):923-30. PubMed ID: 7981322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells.
    Pye A; Curnow A
    Photochem Photobiol; 2007; 83(3):766-73. PubMed ID: 17576385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin-iron chelates are transported via glucose transporters.
    Vlachodimitropoulou E; Sharp PA; Naftalin RJ
    Free Radic Biol Med; 2011 Apr; 50(8):934-44. PubMed ID: 21238582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.
    Porter JB; Gyparaki M; Burke LC; Huehns ER; Sarpong P; Saez V; Hider RC
    Blood; 1988 Nov; 72(5):1497-503. PubMed ID: 3179437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do we need more iron-chelating drugs?
    Kontoghiorghes GJ
    Lancet; 2003 Aug; 362(9382):495-6. PubMed ID: 12927446
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of new iron chelators for clinical use.
    Porter JB
    Acta Haematol; 1996; 95(1):13-25. PubMed ID: 8604583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake and digestion of 125I-labelled bovine serum albumin by the rat visceral yolk sac cultured in vitro as a closed vesicle.
    Dunton A; Pratten MK; Beck F
    Placenta; 1988; 9(3):303-11. PubMed ID: 3140232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection.
    Blake E; Allen J; Curnow A
    Photochem Photobiol; 2011; 87(6):1419-26. PubMed ID: 21834866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adsorptive pinocytosis of 125I-labelled lactate dehydrogenase isoenzymes H4 and M4 by rat yolk sacs incubated in vitro.
    Kooistra T; Williams KE
    Biochem J; 1981 Sep; 198(3):587-93. PubMed ID: 7326025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
    Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
    Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.